Table of Contents Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Research Report 2020, Forecast to 2025 1 Market Overview 1.1 Amyotrophic Lateral Sclerosis (ALS) Treatment Definition 1.1.1 Analysis of Macroeconomic Indicators 1.1.2 Years Considered 1.2 Amyotrophic Lateral Sclerosis (ALS) Treatment Segment by Type 1.2.1 Riluzole 1.2.2 Edaravone (Radicava) 1.2.3 Other 1.3 Market Analysis by Application 1.3.1 Hospital 1.3.2 Drugs Store 1.3.3 Other 1.4 Overview of Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market 1.4.1 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (2015-2025) 1.4.2 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Production and Capacity (2015-2025) 1.4.3 North America Amyotrophic Lateral Sclerosis (ALS) Treatment Status and Prospect (2015-2025) 1.4.4 Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Status and Prospect (2015-2025) 1.4.5 Japan Amyotrophic Lateral Sclerosis (ALS) Treatment Status and Prospect (2014-2025) 1.4.6 China Amyotrophic Lateral Sclerosis (ALS) Treatment Status and Prospect (2015-2025) 1.5 Market Dynamics 1.5.1 Market Opportunities 1.5.2 Market Risk 1.5.3 Market Driving Force 1.5.4 Porter's Five Forces Analysis 1.5.5 SWOT Analysis 1.6 Coronavirus Disease 2019 (Covid-19): Amyotrophic Lateral Sclerosis (ALS) Treatment Industry Impact 1.6.1 How the Covid-19 is Affecting the Amyotrophic Lateral Sclerosis (ALS) Treatment Industry 1.6.2 Amyotrophic Lateral Sclerosis (ALS) Treatment Business Impact Assessment - Covid-19 1.6.3 Market Trends and Amyotrophic Lateral Sclerosis (ALS) Treatment Potential Opportunities in the COVID-19 Landscape 1.6.4 Measures / Proposal against Covid-19 2 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Competition by Manufacturer 2.1 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Sales and Market Share by Manufacturer (2018-2020) 2.2 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue and Market Share by Manufacturer (2018-2020) 2.3 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Industry Concentration Ratio (CR5 and HHI) 2.4 Top 5 Amyotrophic Lateral Sclerosis (ALS) Treatment Manufacturer Market Share 2.5 Top 10 Amyotrophic Lateral Sclerosis (ALS) Treatment Manufacturer Market Share 2.6 Date of Key Manufacturers Enter into Amyotrophic Lateral Sclerosis (ALS) Treatment Market 2.7 Key Manufacturers Amyotrophic Lateral Sclerosis (ALS) Treatment Product Offered 2.8 Mergers & Acquisitions Planning 3 Analysis of Amyotrophic Lateral Sclerosis (ALS) Treatment Industry Key Manufacturers 3.1 Mitsubishi Tanabe Pharma 3.1.1 Company Details 3.1.2 Product Information 3.1.3 Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis (ALS) Treatment Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.1.4 Main Business Overview 3.1.5 Mitsubishi Tanabe Pharma News 3.2 Sanofi 3.2.1 Company Details 3.2.2 Product Information 3.2.3 Sanofi Amyotrophic Lateral Sclerosis (ALS) Treatment Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.2.4 Main Business Overview 3.2.5 Sanofi News 3.3 Mylan Pharma 3.3.1 Company Details 3.3.2 Product Information 3.3.3 Mylan Pharma Amyotrophic Lateral Sclerosis (ALS) Treatment Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.3.4 Main Business Overview 3.3.5 Mylan Pharma News 3.4 Apotex 3.4.1 Company Details 3.4.2 Product Information 3.4.3 Apotex Amyotrophic Lateral Sclerosis (ALS) Treatment Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.4.4 Main Business Overview 3.4.5 Apotex News 3.5 Glemark Generics 3.5.1 Company Details 3.5.2 Product Information 3.5.3 Glemark Generics Amyotrophic Lateral Sclerosis (ALS) Treatment Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.5.4 Main Business Overview 3.5.5 Glemark Generics News 3.6 Covis Pharma 3.6.1 Company Details 3.6.2 Product Information 3.6.3 Covis Pharma Amyotrophic Lateral Sclerosis (ALS) Treatment Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.6.4 Main Business Overview 3.6.5 Covis Pharma News 3.7 Sun Pharma 3.7.1 Company Details 3.7.2 Product Information 3.7.3 Sun Pharma Amyotrophic Lateral Sclerosis (ALS) Treatment Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.7.4 Main Business Overview 3.7.5 Sun Pharma News 3.8 Lunan Pharma 3.8.1 Company Details 3.8.2 Product Information 3.8.3 Lunan Pharma Amyotrophic Lateral Sclerosis (ALS) Treatment Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.8.4 Main Business Overview 3.8.5 Lunan Pharma News 4 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Categorized by Regions (2015-2020) 4.1 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Market Share by Region 4.2 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue Market Share by Region (2015-2019) 4.3 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Sales, Revenue, Price and Gross Margin (2015-2020) 4.4 North America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Detail 4.4.1 North America Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Growth Rate (2015-2020) 4.4.2 North America Amyotrophic Lateral Sclerosis (ALS) Treatment Sales, Revenue, Price and Gross Margin (2015-2020) 4.5 Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Detail 4.5.1 Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Growth Rate (2015-2020) 4.5.2 Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Sales, Revenue, Price and Gross Margin (2015-2020) 4.6 Japan Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Detail 4.6.1 Japan Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Growth Rate (2015-2020) 4.6.2 Japan Amyotrophic Lateral Sclerosis (ALS) Treatment Sales, Revenue, Price and Gross Margin (2015-2020) 4.7 China Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Detail 4.7.1 China Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Growth Rate (2015-2020) 4.7.2 China Amyotrophic Lateral Sclerosis (ALS) Treatment Sales, Revenue, Price and Gross Margin (2015-2020) 5 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Segment by Type 5.1 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue, Sales and Market Share by Type (2015-2020) 5.1.1 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Sales and Market Share by Type (2015-2020) 5.1.2 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue and Market Share by Type (2015-2020) 5.2 Riluzole Sales Growth Rate and Price 5.2.1 Global Riluzole Sales Growth Rate (2015-2020) 5.2.2 Global Riluzole Price (2015-2020) 5.3 Edaravone (Radicava) Sales Growth Rate and Price 5.3.1 Global Edaravone (Radicava) Sales Growth Rate (2015-2020) 5.3.2 Global Edaravone (Radicava) Price (2015-2020) 5.4 Other Sales Growth Rate and Price 5.4.1 Global Other Sales Growth Rate (2015-2020) 5.4.2 Global Other Price (2015-2020) 6 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Segment by Application 6.1 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Market Share by Application (2015-2020) 6.2 Hospital Sales Growth Rate (2015-2020) 6.3 Drugs Store Sales Growth Rate (2015-2020) 6.4 Other Sales Growth Rate (2015-2020) 7 Amyotrophic Lateral Sclerosis (ALS) Treatment Related Market Analysis 7.1 Upstream Analysis 7.1.1 Macro Analysis of Upstream Markets 7.1.2 Key Players in Upstream Markets 7.1.3 Upstream Market Trend Analysis 7.1.4 Amyotrophic Lateral Sclerosis (ALS) Treatment Manufacturing Cost Analysis 7.2 Downstream Market Analysis 7.2.1 Macro Analysis of Down Markets 7.2.2 Key Players in Down Markets 7.2.3 Downstream Market Trend Analysis 7.2.4 Sales Channel, Distributors, Traders and Dealers 8 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Forecast 8.1 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Sales, Revenue Forecast 8.1.1 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Growth Rate Forecast (2020-2025) 8.1.2 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue and Growth Rate Forecast (2020-2025) 8.1.3 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Price and Trend Forecast (2020-2025) 8.2 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Forecast by Region (2020-2025) 8.2.1 North America Amyotrophic Lateral Sclerosis (ALS) Treatment Sales, Revenue Forecast (2020-2025) 8.2.2 Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Sales, Revenue Forecast (2020-2025) 8.2.3 Japan Amyotrophic Lateral Sclerosis (ALS) Treatment Production, Revenue Forecast (2020-2025) 8.2.4 China Amyotrophic Lateral Sclerosis (ALS) Treatment Production, Revenue Forecast (2020-2025) 9 Research Findings and Conclusion 10 Appendix

List of Tables and Figures Figure Amyotrophic Lateral Sclerosis (ALS) Treatment Picture Table Global Amyotrophic Lateral Sclerosis (ALS) Treatment Sales by Type Figure Global Sales Market Share of Amyotrophic Lateral Sclerosis (ALS) Treatment by Product Type in 2019 Table Breakdown of Amyotrophic Lateral Sclerosis (ALS) Treatment by Company Type (Tier 1, Tier 2 and Tier 3) Figure Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3) Figure Riluzole Picture Figure Edaravone (Radicava) Picture Figure Other Picture Table Global Amyotrophic Lateral Sclerosis (ALS) Treatment Sales by Application Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Market Share by Application in 2019 Figure Hospital Picture Figure Drugs Store Picture Figure Other Picture Table Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Comparison by Region (2019-2025) (K Units) & (Million US$) Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (Million US$) (2015-2025) Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Production (K Units) (2015-2025) Figure North America Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (Million US$) Growth Rate (2015-2025) Figure Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (Million US$) Growth Rate (2015-2025) Figure Japan Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (Million US$) Growth Rate (2014-2025) Figure China Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (Million US$) Growth Rate (2015-2025) Table Market Opportunities in Next Few Years Table Market Risks Analysis Table Market Drivers Figure Porter's Five Forces Analysis Table SWOT Analysis Table Global Amyotrophic Lateral Sclerosis (ALS) Treatment Sales by Manufacturer (2018-2020) Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Market Share by Manufacturer in 2019 Table Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue by Manufacturer (2018-2020) Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue Market Share by Manufacturer in 2019 Table Global Amyotrophic Lateral Sclerosis (ALS) Treatment Manufacturers Market Concentration Ratio (CR5 and HHI) Figure Top 5 Amyotrophic Lateral Sclerosis (ALS) Treatment Manufacturer (Revenue) Market Share in 2019 Figure Top 10 Amyotrophic Lateral Sclerosis (ALS) Treatment Manufacturer (Revenue) Market Share in 2019 Table Date of Key Manufacturers Enter into Amyotrophic Lateral Sclerosis (ALS) Treatment Market Table Key Manufacturers Amyotrophic Lateral Sclerosis (ALS) Treatment Product Type Table Mergers & Acquisitions Planning Table Mitsubishi Tanabe Pharma Company Profile Figure Amyotrophic Lateral Sclerosis (ALS) Treatment Product Picture and Specifications of Mitsubishi Tanabe Pharma Table Amyotrophic Lateral Sclerosis (ALS) Treatment Production, Price, Revenue and Gross Margin of 2018-2020 Figure Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share (2018-2020) Table Mitsubishi Tanabe Pharma Main Business Table Mitsubishi Tanabe Pharma Recent Development Table Sanofi Company Profile Figure Amyotrophic Lateral Sclerosis (ALS) Treatment Product Picture and Specifications of Sanofi Table Amyotrophic Lateral Sclerosis (ALS) Treatment Production, Price, Revenue and Gross Margin of 2018-2020 Figure Sanofi Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share (2018-2020) Table Sanofi Main Business Table Sanofi Recent Development Table Mylan Pharma Company Profile Figure Amyotrophic Lateral Sclerosis (ALS) Treatment Product Picture and Specifications of Mylan Pharma Table Amyotrophic Lateral Sclerosis (ALS) Treatment Production, Price, Revenue and Gross Margin of 2018-2020 Figure Mylan Pharma Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share (2018-2020) Table Mylan Pharma Main Business Table Mylan Pharma Recent Development Table Apotex Company Profile Figure Amyotrophic Lateral Sclerosis (ALS) Treatment Product Picture and Specifications of Apotex Table Amyotrophic Lateral Sclerosis (ALS) Treatment Production, Price, Revenue and Gross Margin of 2018-2020 Figure Apotex Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share (2018-2020) Table Apotex Main Business Table Apotex Recent Development Table Glemark Generics Company Profile Figure Amyotrophic Lateral Sclerosis (ALS) Treatment Product Picture and Specifications of Glemark Generics Table Amyotrophic Lateral Sclerosis (ALS) Treatment Production, Price, Revenue and Gross Margin of 2018-2020 Figure Glemark Generics Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share (2018-2020) Table Glemark Generics Main Business Table Glemark Generics Recent Development Table Covis Pharma Company Profile Figure Amyotrophic Lateral Sclerosis (ALS) Treatment Product Picture and Specifications of Covis Pharma Table Amyotrophic Lateral Sclerosis (ALS) Treatment Production, Price, Revenue and Gross Margin of 2018-2020 Figure Covis Pharma Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share (2018-2020) Table Covis Pharma Main Business Table Covis Pharma Recent Development Table Sun Pharma Company Profile Figure Amyotrophic Lateral Sclerosis (ALS) Treatment Product Picture and Specifications of Sun Pharma Table Amyotrophic Lateral Sclerosis (ALS) Treatment Production, Price, Revenue and Gross Margin of 2018-2020 Figure Sun Pharma Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share (2018-2020) Table Sun Pharma Main Business Table Sun Pharma Recent Development Table Lunan Pharma Company Profile Figure Amyotrophic Lateral Sclerosis (ALS) Treatment Product Picture and Specifications of Lunan Pharma Table Amyotrophic Lateral Sclerosis (ALS) Treatment Production, Price, Revenue and Gross Margin of 2018-2020 Figure Lunan Pharma Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share (2018-2020) Table Lunan Pharma Main Business Table Lunan Pharma Recent Development Table Global Amyotrophic Lateral Sclerosis (ALS) Treatment Sales (K Units) by Region (2015-2020) Table Global Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Market Share by Region (2015-2019) Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Market Share by Region (2015-2019) Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Market Share by Region in 2018 Table Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (Million US$) by Region (2015-2020) Table Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue Market Share by Region (2015-2020) Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue Market Share by Region (2015-2020) Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue Market Share by Region in 2019 Table Global Amyotrophic Lateral Sclerosis (ALS) Treatment Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Figure North America Amyotrophic Lateral Sclerosis (ALS) Treatment Sales (K Units) Growth Rate (2015-2020) Figure Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Sales (K Units) Growth Rate (2015-2020) Table Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Figure Japan Amyotrophic Lateral Sclerosis (ALS) Treatment Sales (K Units) Growth Rate (2015-2020) Table Japan Amyotrophic Lateral Sclerosis (ALS) Treatment Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Figure China Amyotrophic Lateral Sclerosis (ALS) Treatment Sales (K Units) Growth Rate (2015-2020) Table China Amyotrophic Lateral Sclerosis (ALS) Treatment Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table Global Amyotrophic Lateral Sclerosis (ALS) Treatment Sales by Type (2015-2020) Table Global Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Market Share by Type (2015-2020) Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Market Share by Type in 2019 Table Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue by Type (2015-2020) Table Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue Market Share by Type (2015-2020) Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue Market Share by Type in 2019 Figure Global Riluzole Sales Growth Rate (2015-2025) Figure Global Riluzole Price (2015-2020) Figure Global Edaravone (Radicava) Sales Growth Rate (2015-2025) Figure Global Edaravone (Radicava) Price (2015-2020) Figure Global Other Sales Growth Rate (2015-2025) Figure Global Other Price (2015-2020) Table Global Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Market Share by Application (2015-2020) Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Sales Market Share by Application in 2019 Figure Global Hospital Sales Growth Rate (2015-2025) Figure Global Drugs Store Sales Growth Rate (2015-2025) Figure Global Other Sales Growth Rate (2015-2025) Table Key Players of Upstream Markets Table Key Raw Materials Figure Price Trend of Key Raw Materials Table Key Suppliers of Raw Materials Figure Manufacturing Cost Structure of Amyotrophic Lateral Sclerosis (ALS) Treatment Table Key Players of Downstream Markets Figure Sales Channel Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Production (K Units) Growth Rate Forecast (2020-2025) Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (Million US$) Growth Rate Forecast (2020-2025) Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Price and Trend Forecast (2020-2025) Table Global Amyotrophic Lateral Sclerosis (ALS) Treatment Sales (K Units) Forecast by Region (2020-2025) Figure Global Amyotrophic Lateral Sclerosis (ALS) Treatment Production Market Share Forecast by Region (2020-2025) Figure North America Amyotrophic Lateral Sclerosis (ALS) Treatment Sales (K Units) Growth Rate Forecast (2020-2025) Figure North America Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (Million US$) Growth Rate Forecast (2020-2025) Figure Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Sales (K Units) Growth Rate Forecast (2020-2025) Figure Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (Million US$) Growth Rate Forecast (2020-2025) Figure Japan Amyotrophic Lateral Sclerosis (ALS) Treatment Production (K Units) Growth Rate Forecast (2020-2025) Figure Japan Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (Million US$) Growth Rate Forecast (2020-2025) Figure China Amyotrophic Lateral Sclerosis (ALS) Treatment Production (K Units) Growth Rate Forecast (2020-2025) Figure China Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (Million US$) Growth Rate Forecast (2020-2025) Figure Methodology/Research Approach Figure Market Size Estimation Figure Author List

Mitsubishi Tanabe Pharma Sanofi Mylan Pharma Apotex Glemark Generics Covis Pharma